Gelesis Holdings - Stock Price History | GLS

Historical daily share price chart and data for Gelesis Holdings since 2022 adjusted for splits. The latest closing stock price for Gelesis Holdings as of July 05, 2022 is 1.74.
  • The all-time high Gelesis Holdings stock closing price was 10.78 on February 09, 2021.
  • The Gelesis Holdings 52-week high stock price is 12.23, which is 602.9% above the current share price.
  • The Gelesis Holdings 52-week low stock price is 1.45, which is 16.7% below the current share price.
  • The average Gelesis Holdings stock price for the last 52 weeks is 7.23.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Gelesis Holdings Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2021 9.9697 10.2700 10.7800 9.7300 9.9600 -1.87%
2020 9.8404 9.8500 10.2600 9.6700 10.1500 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.114B $0.011B
Gelesis is a consumer-centered biotherapeutics company advancing a novel category of treatments for weight management and gut related chronic diseases. Gelesis, formerly known as Capstar Special Purpose Acquisition Corp., is based in BOSTON.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $163.597B 9.95
Bio-Rad Laboratories (BIO.B) United States $14.907B 32.33
QIAGEN (QGEN) Netherlands $10.865B 17.15
Biohaven Pharmaceutical Holding (BHVN) United States $10.248B 0.00
Ginkgo Bioworks Holdings (DNA) United States $4.228B 0.00
Arcus Biosciences (RCUS) United States $1.901B 48.18
Emergent Biosolutions (EBS) United States $1.599B 6.85
Myovant Sciences (MYOV) United Kingdom $1.236B 0.00
Zymeworks (ZYME) Canada $0.320B 0.00
Enzo Biochem (ENZ) United States $0.104B 0.00
Ambrx Biopharma (AMAM) United States $0.103B 0.00
SQZ Biotechnologies (SQZ) United States $0.087B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.000B 0.00